A hospital cohort associated benzodiazepine or barbiturate treatment with alcohol-related readmission, but treatment intensity can mark underlying illness.
What the source reports
The analysis included 932 patients after alcohol-related hospitalizations. Benzodiazepine or barbiturate use during admission or at discharge was associated with 30-day alcohol-related readmission. Other associated factors included withdrawal severity, psychiatric history, and prior alcohol-related admissions. The medication category combined two sedative classes.
Limits of the evidence
Treatment was not randomly assigned. Patients with more severe withdrawal may be more likely both to receive sedatives and to return to hospital. The study could not adequately assess some alcohol-use-disorder medications because few patients received them.
Implications for forensic review
The association should not be described as proof that appropriate withdrawal treatment caused readmission. In a case review, distinguish inpatient treatment from a discharge prescription, document withdrawal severity, and examine access to ongoing care. The underlying clinical risk may explain part of the observed pattern.
Source and related reading
Source reviewed: Medications and Patient Factors Associated With Increased Readmission for Alcohol Related Diagnoses (PMC8704480). This article summarizes the supplied paper; forensic applications above are interpretive analysis.
Related reading: Diazepam Was Part of Treatment After Antipsychotic-Associated Movement Symptoms During Alcohol Withdrawal; A Diazepam Comparator in Rats Does Not Validate Herbal Replacement for Alcohol Withdrawal.
Leave a Reply